Triple Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy: Changes in Liver Fibrosis Scores After 2 Years of Treatment in Patients With New-Onset Type 2 Diabetes Mellitus
Metabolism: Clinical and Experimental - Netherlands
doi 10.1016/j.metabol.2019.12.057
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
Elsevier BV